Koyfin Home > Directory > Health Care > LA Jolla Pharma > Enterprise Value

LA Jolla Pharma Enterprise Value Chart (LJPC)

LA Jolla Pharma annual/quarterly Enterprise Value from 2010 to 2020.
  • LA Jolla Pharma Enterprise Value for the quarter ending October 10, 2020 was $196m a -0.28% decrease of -1m year over year
  • LA Jolla Pharma Enterprise Value for the last 12 months ending October 10, 2020 was $196m a -0.28% decrease of -1m year over year
  • LA Jolla Pharma Annual Enterprise Value for 2020 was $196m a 0.00% decrease of 0m from 2019
  • LA Jolla Pharma Annual Enterprise Value for 2020 was $196m a -0.14% decrease of 0m from 2019
  • LA Jolla Pharma Annual Enterprise Value for 2020 was $197m a -0.14% decrease of 0m from 2019
Other Valuation Metrics:
  • LA Jolla Pharma Market Cap for the quarter ending March 03, 2018 was $777m a 15.21% increase of 118m year over year
  • LA Jolla Pharma Price / Book for the quarter ending March 03, 2018 was 8.09 a 47.74% increase of 3.86 year over year
View Chart On Koyfin

Quarterly LJPC Enterprise Value Data

10/2020$196m
10/2020$196m
10/2020$197m
10/2020$197m
10/2020$194m
10/2020$195m
10/2020$197m
10/2020$192m
10/2020$198m
10/2020$202m

Annual LJPC Enterprise Value Data

2020$196m
2020$196m
2020$197m
2020$197m
2020$194m
2020$195m
2020$197m
2020$192m
2020$198m
2020$202m